LR – Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, and Orano Med, a ...
Canpolat, Ph.D. Origin Story: Dr. Merve Yildirim-Canpolat, Ph.D. and Dr. Polen Koçak-Denizci, Ph.D., both molecular scie ...
Analyst Judah Frommer of Morgan Stanley assigned a Sell rating on 4D Molecular Therapeutics (FDMT – Research Report), with a price target of ...